Amoxicillin and Clavulanate Potassium for Suspension (4:1)
制剂 FDF · Suspension · 250mg/62.5mg
制剂 FDFConfidentiality：公开
- INN / Generic Name
- Amoxicillin and Clavulanate Potassium for Suspension (4:1)
- Dosage Form
- Suspension
- Strength
- 250mg/62.5mg
- Therapy Area
- Infectious Diseases
- Indication
- Respiratory tract infection; Acute bacterial otitis media; Sinusitis; Skin and soft tissue infection; Urinary tract infection
- Current Status
- 官方 FDF 授权目录（UB088）
- GMP Certification
- CN - NMPA; US - FDA
- CEP
- No
- DMF Type
- —
- Stability Data
- —
- BE Required
- Not required / waivable
- Registration Pathway
- 已完成注册（目标市场可转移 / 视市场 DCP·NP）
- MOQ
- 询价
- Lead Time
- 询价
- Price Range
- 询价
Registrable Markets
China
Process / Sequence / Exact Price
- Process Summary
- —
- Exact Price
- —